Gombash, S E
Cowley, C J
Fitzgerald, J A
Lepak, C A
Neides, M G
Hook, K
Todd, L J
Wang, G-D
Mueller, C
Kaspar, B K
Bielefeld, E C
Fischer, A J
Wood, J D
Foust, K D
Article History
Received: 31 March 2017
Revised: 16 June 2017
Accepted: 25 July 2017
First Online: 3 August 2017
Competing interests
: BKK is a shareholder, scientific founder and Chief Scientific Officer of Avexis. KDF is currently an employee of Avexis. The remaining authors declare no conflict of interest.